Pharma industry agrees need of preferential treatments on biologics, but HIRA says “Well…”
Which health insurance standards should biologics, which are evaluated as innovative treatment, meet?
The pharmaceutical industry believes that it is necessary to give preference to Korean new drugs and biologics for global expansion, but the government has been careful over the ‘insurance benef...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
